Triclabendazole
RxNorm 2118525
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2118525 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Triclabendazole.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing triclabendazole (medicinal product)
(Atom ID: 10319411)
INPrescribable
Ingredient (IN):
Triclabendazole
(Atom ID: 10824864)
PTPrescribable
Designated preferred name (PT):
Triclabendazole
(Atom ID: 7735361)
FNPrescribable
Full form of descriptor (FN):
Triclabendazole (substance)
(Atom ID: 7735364)
PTPrescribable
Designated preferred name (PT):
Triclabendazole-containing product
(Atom ID: 10822209)
Patient Education
Triclabendazole
Triclabendazole is used to treat fascioliasis (an infection, usually in the liver and bile ducts, caused by flat worms [liver flukes]) in adults and children 6 years of age and older. Triclabendazole is in a class of medications called anthelmintics. It works by killing the flat worms.
[Learn More]
* Please review the disclaimer below.